Home >Products> Synthesizers | Sequencers | Cell Analysis >Genomics / Sequencers > xGen® Blocking Oligos
Synthesizers | Sequencers | Cell Analysis:  DNA / Organic / Polypeptide Synthesizers   Genomics / Sequencers   Cell Analysis   Proteomics  
xGen® Blocking Oligos
Place of Origin:
United States
Brand:
idt
Model:
Price:
Hits:
3183 
Updated:
9/5/2024
  • Product Detail
  • Company Profile

    Enhance the Performance of Target Capture for Next Generation Sequencing

    xGen® Blocking Oligos bind to platform adapter sequences on a designated strand (usually the inverse of the synthetic adapter) to help prevent non-specific binding, improve the number of reads on-target, and increase the depth of enrichment.

     

    Benefits

    • Increase sample throughput by effectively blocking multiple pooled library adapters with a single blocking oligo
    • Easy and flexible ordering of predesigned sequences that correspond to commonly available adapter library preparation kits

    Features

    • A single xGen® Universal Blocking Oligo effectively blocks multiple barcoded adapters
    • Easily order from predesigned xGen Standard Blocking Oligos for low throughput target capture

     

     

     

    Prevent Adapter Cross-Hybridization

    Adapter sequences specific to the platform being used for next generation sequencing platform are ligated to all library fragments, both on-target and off-target, before enrichment. These adapter sequences can hybridize with each other during enrichment, creating a "daisy-chain" effect in which off-target fragments are captured along with on-target fragments.

    xGen® Blocking Oligos bind to platform adapter sequences on a designated strand (usually the inverse of the synthetic adapter) to help prevent non-specific binding (Figure 1). HPLC purification of your blocking oligos can improve binding to adapter sequences. Introducing end-terminating modifications, such as a 3' C3 spacer, helps to inhibit spurious amplification of blocking oligos.

     

    Enhance Capture Performance by Blocking Platform Adapters

     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    FIGURE 1. BLOCKING OLIGOS INCREASE ON-TARGET READ PERCENTAGE. Several published articles have shown markedly higher on-target percentage by adding oligo blockers. For example, Blumenstiel et al. [1] increased on-target reads from 35% to 59% by including blocking oligos before target capture; Hodges et al. [2] achieved even better performance with blocking oligos, improving their on target reads from 32% before blocking oligos to 64% after the addition of blocking oligos. This approximately two-fold increase in on-target reads allows for multiplexing of a greater number of samples and increases read depth for easier identification of rare alleles.
     

    High and Low Throughput Options with Excellent Peformance

     
     

     

     

     

     

     

     

    References

    1. Blumenstiel B, Cibulskis K, et al. (2010) Targeted exon sequencing by in-solution hybrid selection. Curr Protoc Hum Genet, Chapter 18:Unit 18.4.
    2. Hodges E, Rooks M, et al. (2009) Hybrid selection of discrete genomic intervals on custom-designed microarrays for massively parallel sequencing. Nat Protoc 4(6):960–974.
    bio-equip.cn
    About IDT

    Integrated DNA Technologies (IDT) is a leader in manufacturing and developing products for the research and diagnostics life science market. IDT serves the areas of academic research, biotechnology, and pharmaceutical development. IDT was founded by Dr Joseph Walder in 1987. Since then, its development has been guided by an uncompromising approach to quality, a belief in the value of good service, and a determination to minimize consumer costs.

    Serving over 80,000 life sciences researchers, IDT is widely recognized as the industry leader in custom oligonucleotides due to its capabilities in:

    Analytical Sophistication—IDT pioneered the use of high throughput quality control (QC) methods and is the only oligonucleotide manufacturer to offer purity guarantees and 100% QC. Every oligonucleotide is analyzed by mass spectrometry and purified oligonucleotides receive further analysis by CE and HPLC.
    Design Engineering—IDT maintains an engineering division dedicated to advancing synthesis, processing technology, and automation. An in-house machine shop provides rapid prototyping and custom part design/control.
    Customer Support—IDT received over 100,000 calls last year with an average wait time of only 8 seconds.
    Reagent and Input Control—IDT receives all solvents in large bulk containers, runs QC on all incoming materials, and performs bulk reagent formulation and functional QC on all reagents.
    IDT has over 700 employees serving our worldwide customer base from headquarters in Coralville, Iowa, and facilities in San Diego, California; Leuven, Belgium; and Singapore.
Request Information
Request Information: yes no
Request Quotation: yes no
refresh

I agree to share my inquiry with the other matching suppliers.

Request Information

* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request Information:
yes no
Request Quotation:
yes no
* Message:
* Verification Code:
refresh
I agree to share my inquiry to the other matching suppliers.